Belite Bio Adr Stock Buy Hold or Sell Recommendation
BLTE Stock | USD 63.26 4.18 6.20% |
Given the investment horizon of 90 days and your below-average risk tolerance, our recommendation regarding Belite Bio ADR is 'Strong Sell'. Macroaxis provides Belite Bio buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BLTE positions.
Check out Belite Bio Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Belite and provide practical buy, sell, or hold advice based on investors' constraints. Belite Bio ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
Belite |
Execute Belite Bio Buy or Sell Advice
The Belite recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Belite Bio ADR. Macroaxis does not own or have any residual interests in Belite Bio ADR or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Belite Bio's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
Strong Sell
Market Performance | OK | Details | |
Volatility | Very steady | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Belite Bio Trading Alerts and Improvement Suggestions
Belite Bio ADR appears to be risky and price may revert if volatility continues | |
Net Loss for the year was (31.63 M) with profit before overhead, payroll, taxes, and interest of 0. | |
Belite Bio ADR currently holds about 48.7 M in cash with (29.84 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.96. | |
Belite Bio ADR has a frail financial position based on the latest SEC disclosures | |
Roughly 59.0% of the company shares are held by company insiders | |
Latest headline from gurufocus.com: Lin BioScience Receives U.S. FDA Fast Track Designation For LBS-007 |
Belite Bio current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Belite analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Belite analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Average Consensus Strong Buy
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Belite Bio Returns Distribution Density
The distribution of Belite Bio's historical returns is an attempt to chart the uncertainty of Belite Bio's future price movements. The chart of the probability distribution of Belite Bio daily returns describes the distribution of returns around its average expected value. We use Belite Bio ADR price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Belite Bio returns is essential to provide solid investment advice for Belite Bio.
Mean Return | 0.48 | Value At Risk | -6.09 | Potential Upside | 5.93 | Standard Deviation | 4.10 |
Return Density |
Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Belite Bio historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Belite Stock Institutional Investors
Shares | Jpmorgan Chase & Co | 2024-06-30 | 88.0 | Advisor Group Holdings, Inc. | 2024-06-30 | 8.0 | Marshall Wace Asset Management Ltd | 2024-06-30 | 0.0 | Armistice Capital, Llc | 2024-09-30 | 0.0 | State Street Corp | 2024-06-30 | 15.7 K | Geode Capital Management, Llc | 2024-09-30 | 6.7 K | Citadel Advisors Llc | 2024-09-30 | 6.5 K | Hrt Financial Llc | 2024-06-30 | 5.4 K | Xtx Topco Ltd | 2024-09-30 | 5.4 K | Point72 Asset Management, L.p. | 2024-09-30 | 4.8 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 2.1 K |
Belite Bio Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Belite Bio or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Belite Bio's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Belite stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.38 | |
β | Beta against Dow Jones | 0.68 | |
σ | Overall volatility | 4.19 | |
Ir | Information ratio | 0.08 |
Belite Bio Volatility Alert
Belite Bio ADR shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Belite Bio's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Belite Bio's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Belite Bio Fundamentals Vs Peers
Comparing Belite Bio's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Belite Bio's direct or indirect competition across all of the common fundamentals between Belite Bio and the related equities. This way, we can detect undervalued stocks with similar characteristics as Belite Bio or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Belite Bio's fundamental indicators could also be used in its relative valuation, which is a method of valuing Belite Bio by comparing valuation metrics with those of similar companies.
Better Than Average | Worse Than Average | Compare Belite Bio to competition |
Fundamentals | Belite Bio | Peer Average |
Return On Equity | -0.4 | -0.31 |
Return On Asset | -0.26 | -0.14 |
Current Valuation | 2 B | 16.62 B |
Shares Outstanding | 30.88 M | 571.82 M |
Shares Owned By Insiders | 58.60 % | 10.09 % |
Shares Owned By Institutions | 0.49 % | 39.21 % |
Number Of Shares Shorted | 241.07 K | 4.71 M |
Price To Book | 18.56 X | 9.51 X |
EBITDA | (31.53 M) | 3.9 B |
Net Income | (31.63 M) | 570.98 M |
Cash And Equivalents | 48.7 M | 2.7 B |
Cash Per Share | 1.96 X | 5.01 X |
Total Debt | 886 K | 5.32 B |
Current Ratio | 35.01 X | 2.16 X |
Book Value Per Share | 3.66 X | 1.93 K |
Cash Flow From Operations | (29.84 M) | 971.22 M |
Short Ratio | 2.48 X | 4.00 X |
Earnings Per Share | (1.10) X | 3.12 X |
Target Price | 79.25 | |
Number Of Employees | 20 | 18.84 K |
Beta | -1.6 | -0.15 |
Market Capitalization | 2.08 B | 19.03 B |
Total Asset | 94.64 M | 29.47 B |
Retained Earnings | (71.5 M) | 9.33 B |
Working Capital | 86.31 M | 1.48 B |
Net Asset | 94.64 M |
Belite Bio Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Belite . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Accumulation Distribution | 2316.97 | |||
Daily Balance Of Power | (0.79) | |||
Rate Of Daily Change | 0.94 | |||
Day Median Price | 65.91 | |||
Day Typical Price | 65.03 | |||
Market Facilitation Index | 2.0E-4 | |||
Price Action Indicator | (4.74) | |||
Period Momentum Indicator | (4.18) | |||
Relative Strength Index | 77.34 |
About Belite Bio Buy or Sell Advice
When is the right time to buy or sell Belite Bio ADR? Buying financial instruments such as Belite Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Belite Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Cancer Fighters Thematic Idea Now
Cancer Fighters
Biotech and medical diagnostic companies that work on researching drugs or manufacturing of medical and therapeutics equipment that is directly related to the research, treatment, and detection of cancer or cancer related diseases. The Cancer Fighters theme has 60 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cancer Fighters Theme or any other thematic opportunities.
View All Next | Launch |
Check out Belite Bio Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Belite Bio. If investors know Belite will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Belite Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.10) | Return On Assets (0.26) | Return On Equity (0.40) |
The market value of Belite Bio ADR is measured differently than its book value, which is the value of Belite that is recorded on the company's balance sheet. Investors also form their own opinion of Belite Bio's value that differs from its market value or its book value, called intrinsic value, which is Belite Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Belite Bio's market value can be influenced by many factors that don't directly affect Belite Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Belite Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Belite Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Belite Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.